Berdazimer: Pediatric drug information

The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Reported adverse reactions are for children, adolescents, and adults.

>10%: Local: Application-site pain (≤12%)

1% to 10%:

Local: Application-site dermatitis (≤3%), application-site edema (≤2%), application-site erythema (5% to 6%), application-site pruritus (2% to 4%), application-site vesicles (≤1%), local skin discoloration (≤1%; application site), local skin exfoliation (≤3%; application site)

Miscellaneous: Fever (2%)

<1%:

Dermatologic: Skin erosion (application site)

Local: Application-site irritation